Is Skin-Touch Sham Needle Not Placebo? A Double-Blind Crossover Study on Pain Alleviation

被引:3
|
作者
Takayama, Miho [1 ,2 ,3 ,4 ]
Yajima, Hiroyoshi [1 ,2 ,3 ,4 ]
Kawase, Akiko [2 ,3 ,4 ]
Homma, Ikuo [1 ,2 ,4 ]
Izumizaki, Masahiko [2 ]
Takakura, Nobuari [1 ,2 ,3 ,4 ]
机构
[1] Tokyo Ariake Univ Med & Hlth Sci, Fac Hlth Sci, Dept Acupuncture & Moxibust, Koto Ku, Tokyo 1350063, Japan
[2] Showa Univ, Sch Med, Dept Physiol, Shinagawa Ku, Tokyo 1428555, Japan
[3] Japan Sch Acupuncture Moxibust & Physiotherapy, Shibuya Ku, Tokyo 1500031, Japan
[4] Fdn Oriental Med Res, Shibuya Ku, Tokyo 1500031, Japan
基金
日本学术振兴会;
关键词
RANDOMIZED CONTROLLED-TRIAL; ACUPUNCTURE; DISSOCIATION; MECHANISMS;
D O I
10.1155/2015/152086
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
It remains an open question whether placebo/sham acupuncture, in which the needle tip presses the skin, can be used as a placebo device for research on pain. We compare the analgesic effect of the skin-touch placebo needle with that of the no-touch placebo needle, in which the needle tip does not touch the skin, in a double-blind crossover manner including no-treatment control in 23 healthy volunteers. The subjects received painful electrical stimulation in the forearm before and during needle retention to the LI 4 acupoint and after the removal of the needle and rated pain intensity using a visual analogue scale. We found no significant difference in analgesic effects among the skin-touch placebo needle, no-touch placebo needle, and no-treatment control at every point before, during, and after the treatments (p > 0.05). The results indicate that the skin-touch placebo needle can be used as a placebo device in clinical studies on pain.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Fentanyl buccal soluble film (FBSF) for breakthrough pain in patients with cancer: a randomized, double-blind, placebo-controlled study
    Rauck, R.
    North, J.
    Gever, L. N.
    Tagarro, I.
    Finn, A. L.
    ANNALS OF ONCOLOGY, 2010, 21 (06) : 1308 - 1314
  • [42] A randomised, double-blind, placebo-controlled crossover trial of the influence of the HCN channel blocker ivabradine in a healthy volunteer pain model: an enriched population trial
    Lee, Michael C.
    Bond, Simon
    Wheeler, Daniel
    Scholtes, Ingrid
    Armstrong, Graham
    McNaughton, Peter
    Menon, David
    PAIN, 2019, 160 (11) : 2554 - 2565
  • [43] A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced Neuropathic Pain
    Lynch, Mary E.
    Cesar-Rittenberg, Paula
    Hohmann, Andrea G.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2014, 47 (01) : 166 - 173
  • [44] Effects of anthocyanins on cardiovascular risk factors and inflammation in pre-hypertensive men: a double-blind randomized placebo-controlled crossover study
    Hassellund, S. S.
    Flaa, A.
    Kjeldsen, S. E.
    Seljeflot, I.
    Karlsen, A.
    Erlund, I.
    Rostrup, M.
    JOURNAL OF HUMAN HYPERTENSION, 2013, 27 (02) : 100 - 106
  • [45] Extended-Release Morphine for Chronic Breathlessness in Pulmonary Arterial Hypertension-A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
    Ferreira, Diana H.
    Ekstrom, Magnus
    Sajkov, Dimitar
    Vandersman, Zac
    Eckert, Danny J.
    Currow, David C.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2018, 56 (04) : 483 - 492
  • [46] Effects of anthocyanins on cardiovascular risk factors and inflammation in pre-hypertensive men: a double-blind randomized placebo-controlled crossover study
    S S Hassellund
    A Flaa
    S E Kjeldsen
    I Seljeflot
    A Karlsen
    I Erlund
    M Rostrup
    Journal of Human Hypertension, 2013, 27 : 100 - 106
  • [47] Effects of caffeine ingestion on dynamic visual acuity: a placebo-controlled, double-blind, balanced-crossover study in low caffeine consumers
    Redondo, Beatriz
    Jimenez, Raimundo
    Molina, Ruben
    Dalton, Kristine
    Vera, Jesus
    PSYCHOPHARMACOLOGY, 2021, 238 (12) : 3391 - 3398
  • [48] Caffeine as an Adjuvant Therapy to Opioids in Cancer Pain: A Randomized, Double-Blind, Placebo-Controlled Trial
    Suh, Sang-Yeon
    Choi, Youn Seon
    Oh, Sang Cheul
    Kim, Young Sung
    Cho, Kyunghee
    Bae, Woo Kyung
    Lee, Ju Hyun
    Seo, Ah-ram
    Ahn, Hong-Yup
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2013, 46 (04) : 474 - 482
  • [49] A double-blind placebo-controlled study of brexpiprazole for the treatment of borderline personality disorder
    Grant, Jon E.
    Valle, Stephanie
    Chesivoir, Eve
    Ehsan, Dustin
    Chamberlain, Samuel R.
    BRITISH JOURNAL OF PSYCHIATRY, 2022, 220 (02) : 58 - 63
  • [50] Correlation of Pain Reduction with fMRI BOLD Response in Osteoarthritis Patients Treated with Paracetamol: Randomized, Double-Blind, Crossover Clinical Efficacy Study
    Yue, Yong
    Collaku, Agron
    PAIN MEDICINE, 2018, 19 (02) : 355 - 367